Delivery Order SPE2DB20D1100-SPE2DB24FY78D
Award Date 11/7/23
Potential Completion Date 11/8/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $8,136.80 with a firm fixed price for the delivery of 24,000 units of the medication PERTZYE DR 80S capsule. The contract has an ultimate completion date of July 18, 2025 and was awarded on July 17, 2025. This contract award is not designated as a set-aside....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 units of PERTZYE DR 100S capsules, with a firm fixed price ceiling value of $24,368.76. The ultimate completion date for this delivery order is May 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,726.28 for the supply of 16,000 units of the medication Pertzye DR (pancrelipase) capsules. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $13,179.68, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, with an ultimate completion date of October 12, 2023, is for the delivery of 8,000 units of the medication Pertzye DR capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This contract is part of a larger Indefinite...
- The Defense Logistics Agency awarded a $4,464.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye on June 9, 2025, with an ultimate completion date of June 10, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency awarded a delivery order valued at $21,717.63 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye DR 200S on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside, firm fixed price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Pertzye DR 16,000 unit capsules, with a ceiling value of $31,175.38. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,946.55 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s. This is a firm fixed price, non-set-aside contract awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...